Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
- DOI
- 10.3389/fmolb.2021.793445
- Published
- 2022-02-21
- Container
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fmolb.2021.793445,
title = {Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response},
author = {Wen Tong and Guangyu Wang and Liuyang Zhu and Yi Bai and Zirong Liu and Long Yang and Hao Wu and Tao Cui and Yamin Zhang},
year = {2022},
journal = {Frontiers in Molecular Biosciences},
doi = {10.3389/fmolb.2021.793445},
url = {https://doi.org/10.3389/fmolb.2021.793445}
}RIS
TY - JOUR TI - Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response AU - Wen Tong AU - Guangyu Wang AU - Liuyang Zhu AU - Yi Bai AU - Zirong Liu AU - Long Yang AU - Hao Wu AU - Tao Cui AU - Yamin Zhang PY - 2022 JO - Frontiers in Molecular Biosciences DO - 10.3389/fmolb.2021.793445 UR - https://doi.org/10.3389/fmolb.2021.793445 ER -
APA
Tong, W., Wang, G., Zhu, L., Bai, Y., Liu, Z., Yang, L., Wu, H., Cui, T., & Zhang, Y. (2022). Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2021.793445
Source records
- crossref · retrieved 2026-09-27T15:33:33.337Z